6552
J . Org. Chem. 1996, 61, 6552-6555
High ly Efficien t a n d P r a ctica l Syn th eses of La ven d a m ycin Meth yl
Ester a n d Rela ted Novel Qu in olin d ion es
Mohammad Behforouz,* J alal Haddad, Wen Cai, Macklin B. Arnold, Farahnaz Mohammadi,
Aron C. Sousa, and Mark A. Horn
Department of Chemistry, Ball State University, Muncie, Indiana 47306
Received April 30, 1996X
The novel 7-(N-formyl-, 7-(N-acetyl-, and 7-(N-isobutyrylamino)-2-methylquinoline-5,8-diones were
synthesized in excellent overall yields in three steps via the nitration of the commercially available
8-hydroxy-2-methylquinoline followed by a reduction-acylation step and then oxidation. Acid
hydrolysis of 7-(N-acetylamino)-2-methylquinoline-5,8-dione (14a ) afforded the novel 7-amino-
quinoline-5,8-dione 7 in excellent yields. Due to our efficient preparation of dione 14a , we now
report a short and practical method for the total synthesis of the potent antitumor agent
lavendamycin methyl ester (1b) with an excellent overall yield.
In tr od u ction
No short and efficient methods for the preparation of
7-aminoquinoline-5,8-diones (2) have been reported. This
is mainly due to the fact that direct nucleophilic substi-
tution-reoxidation reactions of quinolinediones cannot
be used because they give mixtures of the C-6 and C-7
substituted products with the predominance of the
undesired C-6 isomer.11-13 Consequently, the current
literature methods involve many steps such as halogena-
tion, oxidation, azidation, and reduction. Serious draw-
backs of these methods are that they are all lengthy and
involve unstable intermediates such as halo- and azi-
doquinones (3, 4).
Quinoline-5,8-diones are an important class of com-
pounds because of their wide spectrum of biological
activities as anitfungal,1a,2,6 antibacterial,1-3 anti-
tumor,1b,2,4,5 antiasthmatic,1b and antiparasitic1-3,6 agents.
It has been proposed that the 7-aminoquinolinedione
segment of the more complex anticancer agents strep-
tonigrin,7 streptonigrone,8 and lavendamycin (1a )9 is
For example, 7-amino-6-methoxy-2-methylquinolinedi-
one (5; streptonigrin A-B ring system) was synthesized
by Liao and co-workers14b from the commercially avail-
able 2-nitroanisidine in six steps with an overall yield of
about 10%, and the preparation of 7-aminoquinoline-5,8-
dione (6; A-B ring system of lavendamycin) from 8-hy-
droxy-2-nitroquinoline has been reported in six steps with
an overall yield of 25%.14a
In our own laboratory, quinone 7 was synthesized in
eight steps16 with an overall yield of 10% from the
commercially available 8-hydroxy-2-methylquinoline (11)
using the existing literature methods for similar systems
(Scheme 1).14a,15
7-Bromo-2-methylquinoline-5,8-dione (8) was prepared
according to the method of Petrow and Sturgeon15 and
then converted to 7, following Boger’s method of prepara-
tion of 7-aminoquinoline-5,8-dione (6).14a
most critical in determining the antitumor activity of
these compounds.10
X Abstract published in Advance ACS Abstracts, August 15, 1996.
(1) (a) Babu, B. H.; Rao, N. V. S. Proc. Ind. Acad. Sci. 1968, 31, and
references cited therein. (b) Hibino, S. Heterocycles 1977, 6, 1485.
(2) Chung-Kyu, R.; Hee-J eong, K. Arch. Pharmacol. Res. 1994, 17,
139, and refences therein.
(3) Wan, Y. P.; Porte, T. H.; Folkers, K. J . Heterocycl. Chem. 1974,
11, 519.
(4) Boger, D. L.; Yasuda, M.; Mitscher, L. A.; Drake, S. D.; Kitos, P.
A., Thompson, S. C. J . Med. Chem. 1987, 30, 1918.
(5) Behforouz, M.; Merriman, R. L. PCT Int. Appl. WO 94 29308,
1994; Chem. Abstr. 122, 239454a.
(6) J eschke, P.; Linder, W.; Mueller, N.; Harder, A.; Mencke, N. Eur.
Patent Appl. EP 519290, 1992; Chem. Abstr. 118, 233893.
(7) (a) Rao, K. V.; Cullen, W. P. Antibiot. Annu. 1959-1960, 950.
(b) Rao, K. V.; Biemann, K.; Woodward, R. B. J . Am. Chem. Soc. 1963,
85, 2532.
(8) Herlt, A. J .; Rickards, R. W., Wu, J .-P. J . Anitbiot. 1985, 38, 516.
(9) (a) Doyle, T. W.; Balitz, D. M.; Grulich, R. E.; Nettleton, D. E.;
Gould, S. J .; Tann, C.; Moews, A. E. Tetrahedron Lett. 1981, 22, 4595.
(b) Balitz, D. M.; Bush, J . A.; Bradner, W. T.; Doyle, T. W.; O’Herron,
F. A.; Nettleton, D. E. J . Antibiot. 1982, 35, 259.
(11) Pratt,y.T.; Drake, N. L J . Am. Chem. Soc. 1959, 82, 1155.
(12) Klimovich,O. S.; Boldyrev, B. G.; Kolesnikov, V. T. Khim.
Geterosikl. Soedine 1975, 11, 1539; Chem. Abstr. 1976, 84, 74064e.
(13) Yoshida, K.; Ishiguro, M.; Honda, H.; Yamamoto, M.; Kubo, Y.
Bull. Chem. Soc. J pn. 1988, 61, 4335 (Eng).
(14) (a) Boger, D. L.; Duff, S. R.; Panek, J . S.; Yasuda, M. J . Org.
Chem. 1985, 50, 5782. (b) Liao, T. K.; Nyberg, W. H.; Cheng, C. C. J .
Heterocycl. Chem. 1976, 13, 1063. (c) Hibino, S.; Weinreb, S. M. J . Org.
Chem. 1977, 42, 232.
(15) Petrow, V.; Sturgeon, B. J . Chem. Soc. 1954, 570.
(16) Azidoquinone 9 was purified by column chromotography (silica
gel, ethyl acetate-hexane 30-70) as a red-orange solid (91%, mp 105-
106°). 1H NMR (CDCl3) δ 8.29 (d, J ) 8 Hz, 1H), 7.56 (d, J ) 8Hz,
1H), 6.49 (s, 1H), 2.78 (s, 3H); HRMS calcd for C10H6N4O2 214.0491,
found 214.0484. Triphenylphosphine amino compound 10 was purified
by column chromotography (silica gel, ethyl acetate-hexane, 3:5, then
7:5) to give purple crystals (62%, mp 215-216°). 1H NMR (CDCl3) δ
8.23 (d, J ) 8 Hz, 1H), 7.75-7.9 (m, 5H), 7.4-7.6 (m, 10H), 7.38 (d, J
) 8 Hz, 1H), 6.52 (s, 1H), 2.64 (s, 3H); HRMS calcd for C22 H21 N2 O2P
448.1341, found 448.1332. Aminoquinone 7 was purified by column
chromotography (silica gel, ethyl acetate-hexane 1:2, then 1:1) as a
red solid (87%).
(10) Rao, K. V. Cancer Chemother. Rep., Part 2 1974, 4(2), 1.
S0022-3263(96)00794-3 CCC: $12.00 © 1996 American Chemical Society